Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1987 2
1988 1
1989 1
1991 4
1992 1
1993 1
1994 1
1995 4
1996 2
1997 3
1998 3
1999 4
2000 2
2001 9
2002 5
2003 8
2004 9
2005 16
2006 14
2007 15
2008 10
2009 14
2010 18
2011 24
2012 27
2013 22
2014 25
2015 34
2016 25
2017 29
2018 25
2019 25
2020 44
2021 42
2022 31
2023 31
2024 37
2025 57
2026 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

567 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
The epidemiology of Parkinson's disease.
Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C. Ben-Shlomo Y, et al. Lancet. 2024 Jan 20;403(10423):283-292. doi: 10.1016/S0140-6736(23)01419-8. Lancet. 2024. PMID: 38245248 Free PMC article. Review.
The epidemiology of Parkinson's disease shows marked variations in time, geography, ethnicity, age, and sex. ...The cause of Parkinson's disease is multifactorial, and involves genetic and environmental factors. Both risk factors ( …
The epidemiology of Parkinson's disease shows marked variations in time, geography, ethnicity, age, and sex. ... …
The Role of Diet and Dietary Patterns in Parkinson's Disease.
Knight E, Geetha T, Burnett D, Babu JR. Knight E, et al. Nutrients. 2022 Oct 25;14(21):4472. doi: 10.3390/nu14214472. Nutrients. 2022. PMID: 36364733 Free PMC article. Review.
Parkinson's Disease (PD) is a neurodegenerative disorder associated with diminished nutrition status and decreased quality of life. ...Although nutrition and diet represent modifiable risk factors for reducing chronic disease risk, research on the impa
Parkinson's Disease (PD) is a neurodegenerative disorder associated with diminished nutrition status and decreased qual
Freezing of gait in Parkinson's disease: pathophysiology, risk factors and treatments.
Gao C, Liu J, Tan Y, Chen S. Gao C, et al. Transl Neurodegener. 2020 Apr 15;9:12. doi: 10.1186/s40035-020-00191-5. eCollection 2020. Transl Neurodegener. 2020. PMID: 32322387 Free PMC article. Review.
BACKGROUND: Freezing of gait (FOG) is a common, disabling symptom of Parkinson's disease (PD), but the mechanisms and treatments of FOG remain great challenges for clinicians and researchers. The main focus of this review is to summarize the possible m …
BACKGROUND: Freezing of gait (FOG) is a common, disabling symptom of Parkinson's disease (PD), but the mechanisms and t …
Update of the MDS research criteria for prodromal Parkinson's disease.
Heinzel S, Berg D, Gasser T, Chen H, Yao C, Postuma RB; MDS Task Force on the Definition of Parkinson's Disease. Heinzel S, et al. Mov Disord. 2019 Oct;34(10):1464-1470. doi: 10.1002/mds.27802. Epub 2019 Aug 14. Mov Disord. 2019. PMID: 31412427 Review.
The MDS Research Criteria for Prodromal PD allow the diagnosis of prodromal Parkinson's disease using an evidence-based conceptual framework, which was designed to be updated as new evidence becomes available. New prospective evidence of …
The MDS Research Criteria for Prodromal PD allow the diagnosis of prodromal Parkinson's disease using an evidence
Prevalence and clinical aspects of depression in Parkinson's disease: A systematic review and meta-analysis of 129 studies.
Cong S, Xiang C, Zhang S, Zhang T, Wang H, Cong S. Cong S, et al. Neurosci Biobehav Rev. 2022 Oct;141:104749. doi: 10.1016/j.neubiorev.2022.104749. Epub 2022 Jun 21. Neurosci Biobehav Rev. 2022. PMID: 35750224 Free article.
Depression is one of the most important non-motor symptoms in Parkinson's disease (PD), but its prevalence and related clinical characteristics are unclear. To this end, we performed a systematic review and meta-analysis based on 129 studies, including …
Depression is one of the most important non-motor symptoms in Parkinson's disease (PD), but its prevalence and related …
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Disease and Injury and Risk Factor Collaborators. GBD 2023 Disease and Injury and Risk Factor Collaborators. Lancet. 2025 Oct 18;406(10513):1873-1922. doi: 10.1016/S0140-6736(25)01637-X. Epub 2025 Oct 12. Lancet. 2025. PMID: 41092926 Free PMC article.
Of the more than 310 000 total data sources used for all GBD 2023 (about 30% of which were new to this estimation round), more than 120 000 sources were used for estimation of disease and injury burden and 59 000 for risk factor estimation, and included vital registration …
Of the more than 310 000 total data sources used for all GBD 2023 (about 30% of which were new to this estimation round), more than 120 000 …
Parkinson disease-associated cognitive impairment.
Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, Weintraub D. Aarsland D, et al. Nat Rev Dis Primers. 2021 Jul 1;7(1):47. doi: 10.1038/s41572-021-00280-3. Nat Rev Dis Primers. 2021. PMID: 34210995 Review.
Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting >1% of the population 65 years of age and with a prevalence set to double by 2030. ...Cholinesterase inhibition is the only high-level evidence-based treatment availabl
Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting >1% of the population 65 years of a
Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses.
Bellou V, Belbasis L, Tzoulaki I, Evangelou E, Ioannidis JP. Bellou V, et al. Parkinsonism Relat Disord. 2016 Feb;23:1-9. doi: 10.1016/j.parkreldis.2015.12.008. Epub 2015 Dec 17. Parkinsonism Relat Disord. 2016. PMID: 26739246 Free article.
BACKGROUND: Parkinson's disease is a neurological disorder with complex pathogenesis implicating both environmental and genetic factors. ...CONCLUSION: Many environmental factors have substantial evidence of association with Parkinson's
BACKGROUND: Parkinson's disease is a neurological disorder with complex pathogenesis implicating both environmental and …
Consensus on the treatment of dysphagia in Parkinson's disease.
Schindler A, Pizzorni N, Cereda E, Cosentino G, Avenali M, Montomoli C, Abbruzzese G, Antonini A, Barbiera F, Benazzo M, Benarroch E, Bertino G, Clavè P, Cortelli P, Eleopra R, Ferrari C, Hamdy S, Huckabee ML, Lopiano L, Marchese-Ragona R, Masiero S, Michou E, Occhini A, Pacchetti C, Pfeiffer RF, Restivo DA, Rondanelli M, Ruoppolo G, Sandrini G, Schapira A, Stocchi F, Tolosa E, Valentino F, Zamboni M, Zangaglia R, Zappia M, Tassorelli C, Alfonsi E. Schindler A, et al. J Neurol Sci. 2021 Nov 15;430:120008. doi: 10.1016/j.jns.2021.120008. Epub 2021 Sep 27. J Neurol Sci. 2021. PMID: 34624796 Free article.
BACKGROUND: Dysphagia is common in Parkinson's disease (PD). The effects of antiparkinsonian drugs on dysphagia are controversial. ...METHODS: A multinational group of experts in the field of neurogenic dysphagia and/or Parkinson's disease
BACKGROUND: Dysphagia is common in Parkinson's disease (PD). The effects of antiparkinsonian drugs on dysphagia are con …
Overview of late-onset psychoses.
Devanand DP, Jeste DV, Stroup TS, Goldberg TE. Devanand DP, et al. Int Psychogeriatr. 2024 Jan;36(1):28-42. doi: 10.1017/S1041610223000157. Epub 2023 Mar 3. Int Psychogeriatr. 2024. PMID: 36866576 Free article. Review.
BACKGROUND: Several etiologies can underlie the development of late-onset psychosis, defined by first psychotic episode after age 40 years. ...In delirium, psychosis is common but controlled evidence is lacking to support psychotropic medication use. Delusions and h …
BACKGROUND: Several etiologies can underlie the development of late-onset psychosis, defined by first psychotic episode after age 40 …
567 results